Capecitabine for ER-positive versus ER-negative breast cancer

Alison M. White; Peter K.H. Lau; Andrew D. Redfern; Max K. Bulsara

doi:10.1002/14651858.CD011220

Capecitabine for ER-positive versus ER-negative breast cancer

Alison M. White
, Peter K.H. Lau
, Andrew D. Redfern
, Max K. Bulsara

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of chemotherapy regimens containing capecitabine compared with regimens not containing capecitabine for women with ER-positive versus ER-negative breast cancer.

Original language	English
Article number	CD011220
Journal	Cochrane Database of Systematic Reviews
Volume	2014
Issue number	8
DOIs	https://doi.org/10.1002/14651858.CD011220
Publication status	Published - 3 Aug 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/14651858.CD011220

Cite this

@article{2b3fecd9f6fe424fa597152caf101619,

title = "Capecitabine for ER-positive versus ER-negative breast cancer",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of chemotherapy regimens containing capecitabine compared with regimens not containing capecitabine for women with ER-positive versus ER-negative breast cancer.",

author = "White, \{Alison M.\} and Lau, \{Peter K.H.\} and Redfern, \{Andrew D.\} and Bulsara, \{Max K.\}",

note = "Funding Information: • Royal Perth Hospital, Australia. Salary • Royal Perth Hospital, Cancer Research Fellowship, WA Health, Australia. Salary • University of Notre Dame, Australia. Salary Publisher Copyright: {\textcopyright} 2014 The Cochrane Collaboration.",

year = "2014",

month = aug,

day = "3",

doi = "10.1002/14651858.CD011220",

language = "English",

volume = "2014",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley \& Sons",

number = "8",

}

TY - JOUR

T1 - Capecitabine for ER-positive versus ER-negative breast cancer

AU - White, Alison M.

AU - Lau, Peter K.H.

AU - Redfern, Andrew D.

AU - Bulsara, Max K.

N1 - Funding Information: • Royal Perth Hospital, Australia. Salary • Royal Perth Hospital, Cancer Research Fellowship, WA Health, Australia. Salary • University of Notre Dame, Australia. Salary Publisher Copyright: © 2014 The Cochrane Collaboration.

PY - 2014/8/3

Y1 - 2014/8/3

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of chemotherapy regimens containing capecitabine compared with regimens not containing capecitabine for women with ER-positive versus ER-negative breast cancer.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of chemotherapy regimens containing capecitabine compared with regimens not containing capecitabine for women with ER-positive versus ER-negative breast cancer.

UR - https://www.scopus.com/pages/publications/85041893162

U2 - 10.1002/14651858.CD011220

DO - 10.1002/14651858.CD011220

M3 - Article

AN - SCOPUS:85041893162

SN - 1465-1858

VL - 2014

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 8

M1 - CD011220

ER -

Capecitabine for ER-positive versus ER-negative breast cancer

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this